2. Executive Summary
Infertility, the inability to conceive by natural means, is a medical condition with high
prevalence affecting nearly 10- 15% of married couples in India. Age is the single biggest factor
affecting women’s chance to conceive a healthy baby. The mean female age of marriage has
increased from 18.3 to 19.3 while the same increase in male is form 22.6 to 23.3 years this has
improved the survival ratio amongst age groups and age specific fertility rate. All these factors
have contributed to a decrease in TFR from 2.5 to 2.2.
There is an increase of 14% in the proportion of women in the age group of 20 to 44 years while
the increase in age group of 30 to 44 years which exhibits low fertility is 20%. This coupled with
key risk factors viz. lifestyle factors and clinical factors promise a market of an estimated 27.5
million people needing treatment.
Indians have high propensity to seek fertility treatment due to various societal pressures and
the need for parenthood and social status associated with it, but awareness is a major barrier.
In India the ART market which includes IVF, GIFT and ZIFT is in its nascent stages with an
estimated 1% of the total infertile couples seeking treatment. The main pain points to be
addressed being affordability, awareness and treatment guarantee.
The low penetration can be attributed to high cost, multiple cycle requirements and follow ups,
paucity of skilled ART doctors, low awareness and a fragmented market. The geographic skew is
so evident that the top 8 metros account for more than 50 % of the cycles carried out.
IVF treatment market has the potential to grow by 18% CAGR. And increase in number of cycles
amounting to 1.6 lakhs at a total market value in excess of $5 billion. The attractiveness of this
field can be gauged by investments made by Bourn Hall and Goldman Sachs PE.
India has the potential to become one of the most favored destination for infertility treatments
due to a cost effective healthcare system.
m, mushrooming of new state of art hospitals and the large talent pool which can be trained at
this specialized treatment.
In India a typical IVF cycle cost $1000 which is paltry in comparison with western average of
$8000-$10000 this represents a huge opportunity for medical tourism which will spur demand.
The expansion of the ART industry has the potential to spur growth in myriad industries at the
national and international levels—clinics and hospitals, health care consultants, semen banks,
cryobanks, donors and donor networks, pharmaceutical companies, the hospitality industry,
state tourism departments, surrogacy agents, surrogacy law firms, and other agencies
specializing in the promotion of medical tourism.
One of the potential stumbling block is lack of standardization and light regulation from the
government which has spurted the growth of sole-practitioners which effects the overall
3. efficacy of IVF treatments. Consolidation and new regulatory policy will lead to rise in demand
and foreign investments in this sector.
With 1.2 billion people and half the people under the age of 25 India provides a promising
landscape for ART. Future imperatives to unlock the full potential of this sector are:
Expanding ART care which includes training, skill-building, improved financing and
adoption of unique treatment techniques.
Building awareness and patient confidence.
Standardization of the process and institution of a regulatory framework.
Clear segmentation between regulated quality providers and non-regulated ART
practitioners.
Compiledby:
MihirShah
9930615334
Pointof Contact:
Uday Bhaskar Jha
+9623781626